IL-6 as a keystone cytokine in health and disease - PubMed (original) (raw)

Review

doi: 10.1038/ni.3153.

Affiliations

Review

IL-6 as a keystone cytokine in health and disease

Christopher A Hunter et al. Nat Immunol. 2015 May.

Erratum in

Abstract

Interleukin 6 (IL-6) has a broad effect on cells of the immune system and those not of the immune system and often displays hormone-like characteristics that affect homeostatic processes. IL-6 has context-dependent pro- and anti-inflammatory properties and is now regarded as a prominent target for clinical intervention. However, the signaling cassette that controls the activity of IL-6 is complicated, and distinct intervention strategies can inhibit this pathway. Clinical experience with antagonists of IL-6 has raised new questions about how and when to block this cytokine to improve disease outcome and patient wellbeing. Here we discuss the effect of IL-6 on innate and adaptive immunity and the possible advantages of various antagonists of IL-6 and consider how the immunobiology of IL-6 may inform clinical decisions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Immunol. 2013 Oct;43(10):2613-25 - PubMed
    1. Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9409-14 - PubMed
    1. J Immunol. 2009 Aug 1;183(3):1732-8 - PubMed
    1. Am J Pathol. 1997 Sep;151(3):689-96 - PubMed
    1. J Biol Chem. 2013 May 24;288(21):14756-68 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources